Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121


Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study.

Li Q, Deng SB, Xia S, Du JL, She Q.

Med Clin (Barc). 2013 Jun 18;140(12):532-6. doi: 10.1016/j.medcli.2012.05.042. Epub 2012 Nov 21.


Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A.

J Am Coll Cardiol. 2009 Aug 4;54(6):558-65. doi: 10.1016/j.jacc.2009.05.028. Epub 2009 Jul 2.


Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

Kim JS, Kim J, Choi D, Lee CJ, Lee SH, Ko YG, Hong MK, Kim BK, Oh SJ, Jeon DW, Yang JY, Cho JR, Lee NH, Cho YH, Cho DK, Jang Y.

JACC Cardiovasc Interv. 2010 Mar;3(3):332-9. doi: 10.1016/j.jcin.2009.11.021. Erratum in: JACC Cardiovasc Interv. 2012 Feb;5(2):248.


Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.

Nusca A, Melfi R, Patti G, Sciascio GD.

Future Cardiol. 2010 Sep;6(5):579-89. doi: 10.2217/fca.10.77. Review.


[Impact of statins on clopidogrel platelet inhibition in patients with acute coronary syndrome or stable angina].

Shen J, Zhang RY, Zhang Q.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Sep;36(9):807-11. Chinese.


Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G; ARMYDA Investigators.

Circulation. 2004 Aug 10;110(6):674-8. Epub 2004 Jul 26.


Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study.

Park Y, Jeong YH, Tantry US, Ahn JH, Kwon TJ, Park JR, Hwang SJ, Gho EH, Bliden KP, Kwak CH, Hwang JY, Kim S, Gurbel PA.

Eur Heart J. 2012 Sep;33(17):2151-62. doi: 10.1093/eurheartj/ehs083. Epub 2012 Apr 16.


Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.

Veselka J, Zemánek D, Hájek P, Malý M, Adlová R, Martinkovicová L, Tesar D.

Am J Cardiol. 2009 Sep 1;104(5):630-3. doi: 10.1016/j.amjcard.2009.04.048. Epub 2009 Jun 24.


Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.

Chyrchel M, Rakowski T, Rzeszutko L, Legutko J, Dziewierz A, Dubiel JS, Dudek D.

Kardiol Pol. 2006 Dec;64(12):1357-62; discussion 1363. English, Polish.


High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period.

Ye H, He F, Fei X, Lou Y, Wang S, Yang R, Hu Y, Chen X.

J Cardiovasc Pharmacol Ther. 2014 May;19(3):290-5. doi: 10.1177/1074248413513500. Epub 2013 Dec 16.


Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.

Tetik S, Ak K, Isbir S, Eksioglu-Demiralp E, Arsan S, Iqbal O, Yardimci T.

Clin Appl Thromb Hemost. 2010 Apr;16(2):189-98. doi: 10.1177/1076029609344980. Epub 2009 Aug 23.


Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes.

Mitsios JV, Papathanasiou AI, Rodis FI, Elisaf M, Goudevenos JA, Tselepis AD.

Circulation. 2004 Mar 23;109(11):1335-8. Epub 2004 Mar 15.


Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study.

Zemánek D, Branny M, Martinkovičová L, Hájek P, Malý M, Tesař D, Tomašov P, Veselka J.

Int J Cardiol. 2013 Oct 3;168(3):2494-7. doi: 10.1016/j.ijcard.2013.03.002. Epub 2013 Apr 15.


Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.

Mostowik M, Siniarski A, Gołębiowska-Wiatrak R, Nessler J, Gajos G.

Adv Clin Exp Med. 2015 Nov-Dec;24(6):979-85. doi: 10.17219/acem/46935.


Effect of intensive atorvastatin therapy on periprocedural PDCD4 expression in CD4+ T lymphocytes of patients with unstable angina undergoing percutaneous coronary intervention.

Su Q, Li L, Liu Y, Zhou Y, Wang J, Sun Y.

Cardiology. 2014;127(3):169-75. doi: 10.1159/000356434. Epub 2014 Jan 14.


Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention.

Veselka J, Zemánek D, Hájek P, Malý M, Adlová R, Martinkovičová L, Tomašov P, Tesař D.

Am J Cardiol. 2011 May 1;107(9):1295-9. doi: 10.1016/j.amjcard.2010.12.040. Epub 2011 Feb 23.


Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.

Liu HL, Yang Y, Yang SL, Luo JP, Li H, Jing LM, Shen ZQ.

Clin Ther. 2013 Mar;35(3):261-72. doi: 10.1016/j.clinthera.2013.01.009. Epub 2013 Feb 12.

Items per page

Supplemental Content

Write to the Help Desk